HER2 was mainly expressed in the nucleus (Figure 3A), and positive expression was observed in 41 of 85 tumour samples, while ERCC1 expression was positive in 50 tumour samples (Figure 3B). This evidence concerns the gene ERCC1 and neoplasm.